Mankind Pharma Ltd. Investor Presentation

Mankind Pharma Ltd. Investor Presentation: Get insights into company performance, financials, capex plans and more

Quarter
All Jul-Sep 2025 Apr-Jun 2025 Jan-Mar 2025 Oct-Dec 2024 Jul-Sep 2024 Apr-Jun 2024 Jan-Mar 2024 Oct-Dec 2023 Jul-Sep 2023 Apr-Jun 2023 Jan-Mar 2023 Oct-Dec 2022 Jul-Sep 2022 Apr-Jun 2022 Jan-Mar 2022 Oct-Dec 2021 Jul-Sep 2021 Apr-Jun 2021 Jan-Mar 2021 Oct-Dec 2020 Jul-Sep 2020 Apr-Jun 2020 Jan-Mar 2020 Oct-Dec 2019 Jul-Sep 2019 Apr-Jun 2019 Jan-Mar 2019 Oct-Dec 2018 Jul-Sep 2018 Apr-Jun 2018 Jan-Mar 2018 Oct-Dec 2017 Jul-Sep 2017 Apr-Jun 2017 Jan-Mar 2017 Oct-Dec 2016 Jul-Sep 2016 Apr-Jun 2016 Jan-Mar 2016 Oct-Dec 2015
announcement
Conference/Earnings Calls Alerts
logo
Mankind Pharma Ltd.
10 Jan 2024
2664.30
3.34%
pdf
logo
Mankind Pharma Ltd.
31 Oct 2023
2664.30
3.34%
pdf
logo
Mankind Pharma Ltd.
02 Aug 2023
2664.30
3.34%
pdf
logo
Mankind Pharma Ltd.
30 May 2023
2664.30
3.34%
Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
In reference to our intimation dated 25th May 2023 under subject 'Intimation of Performance and Business Update Call on Q4FY23 & FY 23 with Senior Management of Mankind Pharma Limited ('the Company')' and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the presentation that would be placed in a Performance and Business update call for Q4FY23 & FY 23 scheduled on Wednesday, 31st May 2023 at 12 noon (IST). The presentation is also being uploaded on the website of the company i.e. www.mankindpharma.com.
pdf